Showing 7371-7380 of 8879 results for "".
- FDA Approves Amendment to Avita's Vitiligo Trial Designhttps://practicaldermatology.com/news/fda-approves-amendment-to-avitas-vitiligo-trial-design/2460893/Avita Medical, Inc. will move forward with an amended pivotal clinical trial evaluating the safety and effectiveness of the RECELL® System for the repigmentation of stable vitiligo lesions to a streamlined single-arm trial design, now that the FDA has approved the trial modification. The
- UV Index Today is Helping to Reduce Skin Cancer Rates with Web Technologyhttps://practicaldermatology.com/news/uv-index-today-is-helping-to-reduce-skin-cancer-rates-with-web-technology/2460891/UV Index Today launched their free UV forecasting service to help people track the sun’s ultraviolet radiation
- MoonLake Immunotherapeutics Taps Former Kymab CEO Simon Sturge as Chairman and Spike Loy for the Board of Directorshttps://practicaldermatology.com/news/moonlake-immunotherapeutics-taps-former-kymab-ceo-simon-sturge-as-chairman-and-spike-loy-for-the-board-of-directors/2460887/Simon Sturge is the new Chairman of MoonLake Immunotherapeutics AG, and Spike Loy has joined the Company’s Board of Directors. Mr. Sturge has 40 years of international leadership experience in the biotechnology and pharmaceutical industry. Most recently, he was Chief Ex
- Industry Veteran Ann Deren-Lewis Joins Mindera as Chief Commercial Officerhttps://practicaldermatology.com/news/industry-veteran-ann-deren-lewis-joins-mindera-as-chief-commercial-officer/2460879/Ann Deren-Lewis is Mindera’s new Chief Commercial Officer. She most recently served as Sr. Vice President of Corporate Development at Zerigo Health (formerly Clarify Medical) where she led commercial operations, including sales, marketing, medical affairs, and the clinical c
- FDA Approves of Sol Gel's Twyneo for Acnehttps://practicaldermatology.com/news/fda-approves-of-sol-gels-twyneo-for-acne/2460874/The FDA has approved Sol Ge's first proprietary drug product, TWYNEO (tretinoin/benzoyl peroxide) cream, 0.1%/3%, for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older. TWYNEO uses Sol-Gel’s patented technology to entrap tretinoin, a retinoid, a
- Sasakawa Leprosy (Hansen's Disease) Launches New "Don't Forget Leprosy" Initiativehttps://practicaldermatology.com/news/sasakawa-leprosy-hansens-disease-new-initiative-dont-forget-leprosy/2460872/Sasakawa Leprosy (Hansen's Disease) Initiative is launching a campaign called "Don't Forget Leprosy" urging that activities against the disease are not sidelined amid the ongoing coronavirus pandemic. Beginning with a webinar on Aug. 4, 2021, the approximately 10-
- Survey: Cleansing Habits of Americans Are Not Up to Dermatologist Standardshttps://practicaldermatology.com/news/survey-cleansing-habits-of-americans-are-not-up-to-dermatologist-standards/2460871/Fully 91 percent of consumers agree that cleansing is important, only 23 percent say that a dermatologist would be pleased with their facial cleansing habits, according to a new survey conducted by CeraVe of 2,000 U.S. adults aged 18-40. This is why this CeraVe is helping
- Rhode Island Takes Steps to Increase Sunscreen Access for Childrenhttps://practicaldermatology.com/news/rhode-island-takes-steps-to-increase-sunscreen-access-for-children/2460866/Rhode Island students will now be able to possess and utilize sunscreen at school and school-related activities, thanks to advocacy from the American Society for Dermatologic Surgery Association (ASDSA) and the Rhode Island Dermatology Society. Governor Daniel McKee signed into la
- CeraVe Research Highlights the Impact of UV Exposure on the Skin Barrier and the Benefits of Ceramideshttps://practicaldermatology.com/news/cerave-research-highlights-the-impact-of-uv-exposure-on-the-skin-barrier-and-the-benefits-of-ceramides/2460859/A skincare regimen that includes a moisturizer and sunscreen formulated with ceramides can help protect against ultraviolet(UV)-induced skin barrier damage and improve skin barrier health overall, according to new research in the Journal of Drugs in Dermatology. The clin
- Vivacare Launches Eczema Education Resources in Collaboration with Allergy & Asthma Networkhttps://practicaldermatology.com/news/vivacare-launches-eczema-education-resources-in-collaboration-with-allergy-asthma-network/2460855/Vivacare has introduced in-depth eczema education resources from the Allergy & Asthma Network. The program will provide helpful resources for more than 3,000 allergists, dermatologists and primary care providers to distribute to their patients. These printable handouts, videos and patient sup